Melanoma

Discontinuing Treatment With Nivolumab Does Not Affect Survival in Patients With Melanoma

06/10/2016

JCP Editors

Discontinuing nivolumab-ipilimumab treatment because of adverse events may not have a detrimental impact on survival among patients with advanced melanoma, according to follow-up from a randomized trial presented at...

...

06/10/2016

Journal of Clinical Pathways

Department

Pembrolizumab Leads to Improved Survival in Patients With Melanoma

06/06/2016

JCP Editors

Patients with advanced melanoma treated with a Programmed cell death protein-1 (PD-1) immune checkpoint inhibitor have longer survival than historically treated patients, according to results from a phase 1 clinical...

...

06/06/2016

Journal of Clinical Pathways

News

Nanotech Drug Delivery Shows Promise for Improved Melanoma Treatment

12/10/2015

PORTLAND, Ore. – Researchers have developed a new three-drug delivery system for cancer treatment, especially metastatic melanoma, the deadliest form of skin cancer - and shown that the system may have particular value with cancers like this...

PORTLAND, Ore. – Researchers...

12/10/2015

IO Learning

News

First Vaccine Approved for Melanoma Treatment

10/28/2015

The Melanoma Research Alliance (MRA) welcomes another exciting new chapter in the treatment of melanoma with the news that the US Food & Drug Administration (FDA) has given approval to Amgen’s immunotherapy drug, IMLYGIC, known as T-VEC for...

The Melanoma Research Alliance...

10/28/2015

IO Learning

Brief Communication

Malignant Melanoma Masquerading as a Decubitus Heel Ulceration

01/01/2006

Marek E. Zelent

David J. Neese

Richard B. Graham

01/01/2006

Wounds